“Doctors and researchers are stunned after an experimental treatment using an anti-parasitic drug — originally designed to fight infections — showed unexpected success against cancer.” (link)
Why not look at it from another angle? Perhaps the anti-parasitic drug is simply doing what it was meant to do — treating a parasitic illness — and what we call cancer may actually be a misdiagnosed or mislabeled condition. With this kind of reasoning, not only could the so-called cancer be treated effectively, but it might also reveal that cancer has been misclassified from the start, much like “viral infections,” where no actual virus has ever been demonstrated to exist.
The reason such logical explanations are ignored is simple: most so-called medical experts — especially physicians — are not trained in real science, such as chemistry, nor in conducting genuine scientific research. As a result, they make unscientific and false claims or assumptions under the banner of “science.”
They continue this pattern by saying, as the article notes, “More research and clinical trials are needed before drawing firm conclusions.” In reality, this is a funding tactic. Clinical trials are not scientific procedures — they are sociology-type surveys that cannot yield valid scientific answers.
If an anti-parasitic drug shows benefit against cancer, that observation alone should be enough to warrant its use. Drug safety has already been established through regulatory approval and decades of prior use. What truly needs to stop is the demands of these endless “studies” led by individuals unqualified in science. Physicians conducting such work and calling it “scientific research” is not science — it is deception.
Ivermectin And Cancer (link)
———————————————————————————————————
From Facebook (link)
Doctors and researchers are stunned after an experimental treatment involving an anti-parasitic medication, originally used to fight infections, showed unexpected success against cancer. In this case, the patient… once diagnosed with terminal cancer… responded so well that scans revealed significant tumor regression.
Early studies suggest the drug may disrupt cancer cell metabolism and activate immune responses that help the body fight tumors more effectively. While the results are still preliminary and based on a small number of cases, scientists are hopeful. Repurposing existing medications could offer a faster, more affordable path to new cancer treatments… one that bypasses years of traditional development.
Medical experts caution that more research and clinical trials are essential before drawing firm conclusions. Still, this discovery underscores how innovation… and a willingness to explore unexpected ideas… continues to push the boundaries of modern medicine.
Could the next big breakthrough in cancer treatment already exist on pharmacy shelves?